TITLE

Gastric Carcinoma With Osteoclast-Like Giant Cells

AUTHOR(S)
Baschinsky, Dmitry Y.; Frankel, Wendy L.; Niemann, Theodore H.
PUB. DATE
June 1999
SOURCE
American Journal of Gastroenterology;Jun1999, Vol. 94 Issue 6, p1678
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Extrasketetal neoplasms with osteoclast-like giant cells are uncommon. These tumors are most frequently reported in the breast and pancreas, and are relatively rare in other sites. We report a case of primary gastric adenocarcinoma with an infiltrate of osteoclast-like giant cells. The patient is a 64-yr-old black woman who presented with epigastric pain and was found to have a mass in the gastric antrum. Histological examination showed a poorly differentiated adenocarcinoma with an infiltrate of osteoclast-like giant cells, The giant cells were present both in the primary gastric adenocarcinoma and in the lymph node metastases. Immunohistochemical stains demonstrated that the giant cells were of monocytic/histiocytic origin and probably represent a distinctive host response to the tumor. The patient is alive and well 12 months alter resection. This is the second published report of gastric carcinoma with osteoclast-like giant cells. Based on this limited experience, gastric carcinoma with osteoclast-like giant cells may represent a distinct clinicopathological entity with a more favorable prognosis.
ACCESSION #
16454459

 

Related Articles

  • α-Fetoprotein-Producing Hepatoid Gastric Adenocarcinoma With Osteoclast-Like Giant Cells and Neuroendocrine Differentiation. Wincewicz, Andrzej; Kowalik, Artur; Zięba, Sebastian; Lewitowicz, Piotr; Góźdź, Stanisław; Sulkowski, Stanisław // International Journal of Surgical Pathology;Oct2015, Vol. 23 Issue 7, p537 

    Here we present the case of a 73-year-old woman with an ulcerated, advanced, hepatoid, and α-fetoprotein-producing poorly differentiated (G3) primary gastric adenocarcinoma pT3 N3a M1 with multinucleated cells and evident neuroendocrine component. This tumor was consistent with giant cell...

  • Factors Correlated With Number of Metastatic Lymph Nodes in Gastric Cancer. King-Han Shen; Chew-Wun Wu; Su-Shun Lo; Mao-Chih Hsieh; Cheng-Yuan Hsia; Shu-Chiung Chiang; Wing-Yiu Lui // American Journal of Gastroenterology;Jan1999, Vol. 94 Issue 1, p104 

    Objective: We had previously reported a reasonable categorization of the number of positive lymph nodes (LN: 0, 1-4, 5-8, and > 8) as a prognostic indicator. This study was an extension, to see which factors correlated with number of positive lymph nodes. Methods: A total of 533 patients with...

  • Individual Prognostic Factors in Gastric Cancer. Hintea, A; Dobre, A; Coroş, M; Ancuţa, Roşca; Daniela, Dobru // Acta Medica Marisiensis;Jun2015, Vol. 61 Issue 2, p67 

    Objectives: The objective of this research was to study the prognostic factors in gastric cancer. Methods: We conducted a retrospective study on 5-year survival in 112 patients with gastric adenocarcinoma operated between 2004-2009. We used the Surgery Clinic I and Health Insurance House...

  • Prognostic significance of genotyping Helicobacter pylon infection in patients in younger age groups with gastric cancer. Tiwari, S. K.; Manoj, G.; Vasanth Kumar, G.; Sivaram, G.; Hassan, S. I.; Prabhakar, B.; Devi, U.; Jalaluddin, S.; Kumar, K.; Ahmed, S.; Abid, Z.; Habeeb, M. A.; Khan, A. A.; C. M. Habibullah // Postgraduate Medical Journal;Apr2008, Vol. 84 Issue 990, p193 

    Malignant tumours of the stomach are common, but the incidence of stomach cancer varies from country to country, probably a result of genetic, epigenetic and environmental factors. Stomach cancer often occurs in older people whose stomachs produce only small quantities of acid. Although...

  • Younger people with gastric cancer have poor prognosis.  // Nursing Standard;8/5/2009, Vol. 23 Issue 48, p16 

    This article reports on the medical prognosis for patients with gastric adenocarcinoma who are under the age of 35. The article discusses the increased risk in these younger patients due to more aggressive tumours. Information is also provided on outcomes for patients at different stages of...

  • Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients. Yang, Xiao-bo; Zhao, Jing-jing; Huang, Chun-yu; Wang, Qi-jing; Pan, Ke; Wang, Dan-dan; Pan, Qiu-zhong; Jiang, Shan-shan; Lv, Lin; Gao, Xiang; Chen, Huang-wei; Yao, Jia-yin; Zhi, Min; Xia, Jian-chuan // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background: FOXO3a, a member of the forkhead class ‘O’ (FOXO) transcription factor family, controls a wide spectrum of biological processes, such as DNA damage repair, apoptosis, and cell cycle regulation. FOXO3a has been shown to be a tumor suppressor in various cancers. This study...

  • Signal Transduction Proteins in Tumors From Puerto Rican and Caucasian Gastric Adenocarcinoma Patients: Expression Differences With Potential for Specific Targeted Therapies. José Cangiano; William Cáceres; Ana de Jesús; Orestes Pavía; Richard Jove; Luis Báez; Carlos Muro-Cacho; Teresita Muñoz-Antonia // Digestive Diseases & Sciences;Aug2008, Vol. 53 Issue 8, p2090 

    Abstract  Overexpression of the HER2/NEU gene is associated with aggressive behavior and poor prognosis in breast cancer, making the Her2/neu protein a directed-therapy target. Tumors of two Puerto Rican (PR) patients overexpressed Her2/neu and resulting partial clinical responses...

  • Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene. Nöckel, Jessica; van den Engel, Natasja K.; Winter, Hauke; Hatz, Rudolf A.; Zimmermann, Wolfgang; Kammerer, Robert // BMC Cancer;2006, Vol. 6, p1 

    Background: Gastric carcinoma is one of the most frequent cancers worldwide. Patients with gastric cancer at an advanced disease stage have a poor prognosis, due to the limited efficacy of available therapies. Therefore, the development of new therapies, like immunotherapy for the treatment of...

  • Combined choriocarcinoma, neuroendocrine cell carcinoma and tubular adenocarcinoma in the stomach. Hirano, Yasumitsu; Hara, Takuo; Nozawa, Hiroshi; Oyama, Kaeko; Ohta, Naohiro; Omura, Kenji; Watanabe, Go; Niwa, Hideki; Yamamoto, Takayuki; Nakamura, Hiroki // World Journal of Gastroenterology;5/28/2008, Vol. 14 Issue 20, p3269 

    We described a patient with adenocarcinoma of the stomach combined with choriocarcinoma and neuroendocrine cell carcinoma. An 85-year-old man visited our hospital because of appetite loss. Gastric fiberscopy revealed a large tumor occupying the cardial region and anterior wall of the gastric...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics